The Recall Desk
ModerateFDA (Drugs)·D-0030-2026·Announced 2025-10-29

Gabapentin capsules recalled after stability testing found unknown impurity out of specification

The Harvard Drug Group is recalling Gabapentin Capsules USP 100 mg across several lots after routine stability testing returned an out-of-specification result for highest unknown impurity.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: Scored 2 as a specification failure: the record cites an out-of-specification unknown impurity without naming it, describing a health consequence, or reporting injury.

Plain-English summary

Gabapentin Capsules, USP, 100 mg, in 100-capsule blister packs, packaged and distributed by Major Pharmaceuticals of Indianapolis, Indiana, are being recalled for failed impurities and degradation specifications.

An out-of-specification result was obtained during routine stability testing for highest unknown impurity.

The recall covers lots including M04950 (expiring January 2026), M04989 and M04990 (expiring February 2026) and M05056 (expiring April 2026), carrying NDC 0904-6665-61. The product was distributed nationwide in the United States. The FDA has classified the recall as Class II.

The enforcement record states the specification failure without naming the impurity or describing a health consequence, and reports no injuries. Gabapentin is a prescription medicine, so patients holding an affected lot should contact their pharmacy or prescriber about a replacement rather than stopping treatment on their own.

The recalled product

Product
GABAPENTIN (GABAPENTIN)
Brand
GABAPENTIN
Manufacturer
The Harvard Drug Group LLC
Category
Drug — Anticonvulsant
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (17)

  • Lot # M04950
  • Exp Date: 01/2026
  • Lot # M04989
  • M04990
  • Exp Date: 02/2026
  • Lot # M05056
  • Exp Date: 04/2026
  • Lot # M05150
  • Exp Date: 07/2026
  • Lot # M05290
  • Exp Date: 11/2026
  • Lot # M05312
  • M05342
  • Exp Date: 01/2027
  • Lot # M05369
  • M05386
  • Exp Date: 02/2027.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by The Harvard Drug Group LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same brand · GABAPENTIN

Same manufacturer · The Harvard Drug Group LLC

See all →

Same hazard · impurity

See all →